People with schizophrenia suffer from great disability and loss of autonomy. Transitional discharge care aims to guarantee continuity of care for people with schizophrenia through discharge planning and subsequent community follow-up and support. There are two fundamental concepts which support the transitional discharge intervention:

1. overlap of hospital and community staff until a therapeutic relationship is established with the community care provider; and
2. peer support from someone with the lived experience of mental illness who has successfully transitioned to the community.

We are looking for consumer input on a Cochrane review that aimed to find out the effects of transitional discharge interventions for people with schizophrenia. The protocol was published in 2019: https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD009788.pub2/full (N.B. the condition of focus changed to schizophrenia from serious mental illness in the published protocol for better consistency).

Cochrane considers a consumer, in this case, to be a carer of somebody with schizophrenia, or who has taken part in the shared decision-making for somebody with schizophrenia. For consumer peer review, we will ask you to complete a short form with your feedback to ensure the review is accessible and relevant so that it will be helpful to patients and their carers/families with healthcare decision-making.

You are welcome to provide feedback on any aspect of the review, or you can focus your attention on the sections you feel are most relevant to consumers and stakeholders, such as Abstract, Plain Language Summary, and Conclusions. Our aim is for this to be a manageable task, that does not overburden consumer reviewers.

Thank you in advance for considering!